CA2280960C - Oxirancarboxylic acids for the treatment of diabetes - Google Patents

Oxirancarboxylic acids for the treatment of diabetes Download PDF

Info

Publication number
CA2280960C
CA2280960C CA002280960A CA2280960A CA2280960C CA 2280960 C CA2280960 C CA 2280960C CA 002280960 A CA002280960 A CA 002280960A CA 2280960 A CA2280960 A CA 2280960A CA 2280960 C CA2280960 C CA 2280960C
Authority
CA
Canada
Prior art keywords
substituted
condition
formula
lower alkyl
het
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002280960A
Other languages
English (en)
French (fr)
Other versions
CA2280960A1 (en
Inventor
Horst P. O. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2280960A1 publication Critical patent/CA2280960A1/en
Application granted granted Critical
Publication of CA2280960C publication Critical patent/CA2280960C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/48Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CA002280960A 1997-02-14 1998-02-05 Oxirancarboxylic acids for the treatment of diabetes Expired - Fee Related CA2280960C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19705718A DE19705718A1 (de) 1997-02-14 1997-02-14 Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
DE19705718.7 1997-02-14
PCT/EP1998/000611 WO1998035952A1 (de) 1997-02-14 1998-02-05 Oxirancarbonsäuren für die behandlung von diabetes

Publications (2)

Publication Number Publication Date
CA2280960A1 CA2280960A1 (en) 1998-08-20
CA2280960C true CA2280960C (en) 2007-04-17

Family

ID=7820279

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002280960A Expired - Fee Related CA2280960C (en) 1997-02-14 1998-02-05 Oxirancarboxylic acids for the treatment of diabetes

Country Status (10)

Country Link
US (2) US6479676B1 (US06670481-20031230-C00004.png)
EP (1) EP0966455B1 (US06670481-20031230-C00004.png)
JP (1) JP3357378B2 (US06670481-20031230-C00004.png)
AT (1) ATE258550T1 (US06670481-20031230-C00004.png)
AU (1) AU6394698A (US06670481-20031230-C00004.png)
CA (1) CA2280960C (US06670481-20031230-C00004.png)
DE (2) DE19705718A1 (US06670481-20031230-C00004.png)
DK (1) DK0966455T3 (US06670481-20031230-C00004.png)
PT (1) PT966455E (US06670481-20031230-C00004.png)
WO (1) WO1998035952A1 (US06670481-20031230-C00004.png)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8013014B2 (en) * 2002-07-05 2011-09-06 Georgia Tech Research Corporation Aza-peptide epoxides
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
WO2004071458A2 (en) 2003-02-13 2004-08-26 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
AU2005214388A1 (en) * 2004-02-18 2005-09-01 Georgia Tech Research Corporation Propenoyl hydrazides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0025192B1 (de) * 1979-09-07 1983-05-11 Byk Gulden Lomberg Chemische Fabrik GmbH Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
US4337267A (en) 1980-08-25 1982-06-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenalkoxyalkyl- and phenoxyalkyl-substituted oxiranecarboxylic acids, their use and medicaments containing them
JPS58501124A (ja) * 1981-07-24 1983-07-14 ビイク グルデン ロンベルク ヒエ−ミツシエ フアブリ−ク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング フエニルアルキルオキシランカルボン酸、その製法、その使用及びそれを含有する医薬品
WO1987000751A2 (en) * 1985-08-02 1987-02-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of oxirancarboxylic acids for the treatment of hyperlipemia
US4788306A (en) * 1987-04-03 1988-11-29 American Home Products Corporation Fluorooxirane carboxylates as hypoglycemic agents
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
GB9209628D0 (en) * 1992-05-05 1992-06-17 Smithkline Beecham Plc Compounds
WO1998000422A1 (en) * 1996-07-02 1998-01-08 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method

Also Published As

Publication number Publication date
AU6394698A (en) 1998-09-08
EP0966455B1 (de) 2004-01-28
DK0966455T3 (da) 2004-05-17
JP2000509726A (ja) 2000-08-02
US6479676B1 (en) 2002-11-12
EP0966455A1 (de) 1999-12-29
JP3357378B2 (ja) 2002-12-16
US6670481B2 (en) 2003-12-30
PT966455E (pt) 2004-08-31
ATE258550T1 (de) 2004-02-15
DE59810675D1 (de) 2004-03-04
DE19705718A1 (de) 1998-08-20
US20020198382A1 (en) 2002-12-26
CA2280960A1 (en) 1998-08-20
WO1998035952A1 (de) 1998-08-20

Similar Documents

Publication Publication Date Title
US5380738A (en) 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
WO2017180818A1 (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof
GB2196962A (en) Substituted 2-benzyl-mercapto-imidazoles and analogs useful as anti-inflammatory agents
FR2567882A1 (fr) Nouvelles 1,5-benzothiazepines a activite cardiovasculaire, procedes pour leur preparation et compositions pharmaceutiques les contenant
EP0285219B1 (en) Method of improving sleep
JPH072831A (ja) ベータ−3選択性アドレナリン作動剤としてのアミノシクロアルカノベンゾジオキソール類
CA2280960C (en) Oxirancarboxylic acids for the treatment of diabetes
DK158460B (da) Analogifremgangsmaade til fremstilling af substituerede oxocarboxylsyrer
EP0463944B1 (fr) Acyl benzoxazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
KR950001040B1 (ko) 티오우레아 유도체 및 이를 함유하는 항균제 및 항궤양제
FR2521992A1 (fr) Nouveaux composes de pyridine utiles comme medicaments
JPH01313464A (ja) 血糖低下剤であるアルキルピペラジニルピリジン
US5681843A (en) Parabanic acid derivatives
JPH0578554B2 (US06670481-20031230-C00004.png)
US4276299A (en) 1-(3-Bromo-isoxazol-5-yl)-2-tert.butylaminoethanol
EP0017352A2 (en) Chromanone derivatives, a process for their preparation, compositions containing them
US4316899A (en) Chromanone derivatives, a process for their preparation and compositions containing them
US4042584A (en) Ethynylaryl phenyl cyclopropyl thiazines and morpholines
EP0429324B1 (fr) Application du N-méthyl (pyridyl-3)-2 tétrahydrothiopyrannecarbothioamide-2-oxyde-1-(1R,2R) à la préparation de médicaments destinés au traitement de l'insuffisance coronarienne
US4349547A (en) Suppressing obesity and over-secretion of insulin with 2-(α-hydroxy-m-trifluoromethylbenzyl)azetidine
JP2535533B2 (ja) ベンゾジオキソ−ル誘導体
US5334602A (en) Aryloxalkylamine derivatives and uses thereof
EP0424214A1 (fr) Dérivés de 5-[2-[[2-amino-2-oxoéthyl]méthylamino]éthyl]-2,3-dihydro-3-hydroxy-2-(4-méthoxy-phényl)-1,5(5H)-benzothiazépine-4-one, leur préparation et leur application en thérapeutique
CA2107818A1 (en) Arylalkoxythiocoumarins, the preparation thereof and therapeutic composions containing these
KR880000043B1 (ko) N-아릴-피레라진알칸아미드의 제조법

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20130205